AquaBounty Technologies (AQB) had the highest return between January 1, 2017 and March 3, 2017 by a US stock, returning 4,033,233.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
AquaBounty Technologies (AQB) | 1/1/2017 - 3/3/2017 | 4,033,233.33% |
Iqstel (IQST) | 1/1/2017 - 3/3/2017 | 6,034% |
Avalon GloboCare (ALBT) | 1/1/2017 - 3/3/2017 | 5,888.02% |
Ocean Power Technologies (OPTT) | 1/1/2017 - 3/3/2017 | 1,597.99% |
Pulmatrix (PULM) | 1/1/2017 - 3/3/2017 | 601.79% |
Duos Technologies (DUOT) | 1/1/2017 - 3/3/2017 | 442.86% |
Castellum (CTM) | 1/1/2017 - 3/3/2017 | 321.05% |
Talos Energy (TALO) | 1/1/2017 - 3/3/2017 | 219.34% |
Viridian Therapeutics (VRDN) | 1/1/2017 - 3/3/2017 | 198.13% |
authID (AUID) | 1/1/2017 - 3/3/2017 | 175% |
Matinas BioPharma (MTNB) | 1/1/2017 - 3/3/2017 | 172.66% |
Coda Octopus (CODA) | 1/1/2017 - 3/3/2017 | 168.24% |
Gravity (GRVY) | 1/1/2017 - 3/3/2017 | 159.35% |
Esperion Therapeutics (ESPR) | 1/1/2017 - 3/3/2017 | 144.14% |
Versus Systems Inc. (VS) | 1/1/2017 - 3/3/2017 | 136.09% |
Pulse Biosciences (PLSE) | 1/1/2017 - 3/3/2017 | 128.92% |
BTCS (BTCS) | 1/1/2017 - 3/3/2017 | 126.57% |
Cronos (CRON) | 1/1/2017 - 3/3/2017 | 126.16% |
Applied Opt (AAOI) | 1/1/2017 - 3/3/2017 | 124.88% |
Aurinia Pharmaceuticals (AUPH) | 1/1/2017 - 3/3/2017 | 124.77% |
Oncolytics Biotech (ONCY) | 1/1/2017 - 3/3/2017 | 119.55% |
Aehr Test Systems (AEHR) | 1/1/2017 - 3/3/2017 | 117.52% |
Ryvyl (RVYL) | 1/1/2017 - 3/3/2017 | 117.42% |
Protalix Biotherapeutics (PLX) | 1/1/2017 - 3/3/2017 | 116.62% |
Quoin Pharmaceuticals Ltd DRC (QNRX) | 1/1/2017 - 3/3/2017 | 111.29% |
